Why Ascendis CEO is leaving

PUBLISHED: Thu, 01 Mar 2018 15:10:29 GMT


JSE listed Pharmaceutical company, Ascendis Health reported a 27 per cent increase in half year revenue to R4 billion, driven by the strong performance of the group’s international operations which grew revenue by 50 per cent to R1.9 billion.

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.